James Norris to Doxorubicin
This is a "connection" page, showing publications James Norris has written about Doxorubicin.
Connection Strength
0.178
-
Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Cancer Gene Ther. 2002 Feb; 9(2):164-72.
Score: 0.178